ZOLEA, Fabiana
 Distribuzione geografica
Continente #
NA - Nord America 203
EU - Europa 110
AS - Asia 45
AF - Africa 6
OC - Oceania 1
Totale 365
Nazione #
US - Stati Uniti d'America 197
UA - Ucraina 49
DE - Germania 26
SG - Singapore 24
CN - Cina 14
SE - Svezia 11
FI - Finlandia 8
AT - Austria 7
CA - Canada 6
SN - Senegal 6
IT - Italia 5
TR - Turchia 5
BE - Belgio 2
FR - Francia 2
KR - Corea 2
AU - Australia 1
Totale 365
Città #
Chandler 44
Jacksonville 28
San Mateo 23
Singapore 17
Boardman 14
Dearborn 11
Ashburn 8
Helsinki 8
New York 8
Lawrence 7
Roxbury 7
Dakar 6
Ottawa 6
Izmir 5
Wilmington 5
Des Moines 4
Beijing 3
Falkenstein 3
Rende 3
Vienna 3
Brooklyn 2
Brussels 2
Cambridge 2
Fremont 2
Guangzhou 2
Inglewood 2
Seoul 2
Ann Arbor 1
Baoding 1
Bremen 1
Changchun 1
Hanover 1
Harbin 1
Los Angeles 1
Melbourne 1
Munich 1
Newark 1
Norwalk 1
Ogden 1
Palermo 1
Redmond 1
San Francisco 1
Shanghai 1
Totale 243
Nome #
Cross talk of estrogen (E2) and IGF-II signalling in adrenocortical tumor cell proliferation. 71
GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo 69
Central role of estrogen receptor α in adrenocortical tumor cell proliferation. 62
Nandrolone and stanozolol induce Leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system 45
Gper and ESRs are expressed in rat round spermatids and mediate oestrogen-dependent rapid pathways modulating expression of cyclin B1 and Bax 44
Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: Potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment 43
Inhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of leydig tumor cells 40
Totale 374
Categoria #
all - tutte 3.106
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.106


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202033 0 0 0 0 0 12 2 5 4 0 8 2
2020/202158 10 5 7 7 1 5 0 7 4 7 0 5
2021/202282 0 13 0 7 7 1 2 24 1 0 10 17
2022/202377 13 12 6 14 9 9 0 4 5 3 0 2
2023/202438 1 3 6 1 2 12 1 0 2 3 1 6
2024/202553 10 16 2 10 6 9 0 0 0 0 0 0
Totale 374